Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Market Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Latin America
6.2 By Country
7 Industry Opportunities and Challenges
8 Latin America Contract Research Organisation (CRO) Services Market Analysis
8.1 Key Industry Highlights
8.2 Latin America Contract Research Organisation (CRO) ServicesHistorical Market (2019-2025)
8.3 Latin America Contract Research Organisation (CRO) Services Market Forecast (2026-2035)
8.4 Latin America Contract Research Organisation (CRO) Services Market by Service Type
8.4.1 Early Phase Development
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2019-2025)
8.4.1.3 Forecast Trend (2026-2035)
8.4.1.4 Breakup by Type
8.4.1.4.1 Discovery Services
8.4.1.4.2 Chemistry
8.4.1.4.3 Preclinical Services
8.4.2 Clinical Research Services
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2019-2025)
8.4.2.3 Forecast Trend (2026-2035)
8.4.2.4 Breakup by Type
8.4.2.4.1 Phase I
8.4.2.4.2 Phase II
8.4.2.4.3 Phase III
8.4.2.4.4 Phase IV
8.4.3 Laboratory Services
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2019-2025)
8.4.3.3 Forecast Trend (2026-2035)
8.4.3.4 Breakup by Type
8.4.3.4.1 Bioanalytical Services
8.4.3.4.2 Analytical Services
8.4.3.4.3 Others
8.4.4 Consulting Services
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2019-2025)
8.4.4.3 Forecast Trend (2026-2035)
8.4.5 Data Management Services
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2019-2025)
8.4.5.3 Forecast Trend (2026-2035)
8.5 Latin America Contract Research Organisation (CRO) Services Market by Therapeutic Area
8.5.1 Oncology
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2019-2025)
8.5.1.3 Forecast Trend (2026-2035)
8.5.2 Clinical Pharmacology
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2019-2025)
8.5.2.3 Forecast Trend (2026-2035)
8.5.3 Cardiovascular
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2019-2025)
8.5.3.3 Forecast Trend (2026-2035)
8.5.4 Infectious Disease
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2019-2025)
8.5.4.3 Forecast Trend (2026-2035)
8.5.5 Neurology
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2019-2025)
8.5.5.3 Forecast Trend (2026-2035)
8.5.6 Gastroenterology and Hepatology
8.5.6.1 Market Share
8.5.6.2 Historical Trend (2019-2025)
8.5.6.3 Forecast Trend (2026-2035)
8.5.7 Respiratory
8.5.7.1 Market Share
8.5.7.2 Historical Trend (2019-2025)
8.5.7.3 Forecast Trend (2026-2035)
8.5.8 Others
8.6 Latin America Contract Research Organisation (CRO) Services Market by End Use
8.6.1 Pharmaceutical and Biopharmaceutical Companies
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2019-2025)
8.6.1.3 Forecast Trend (2026-2035)
8.6.2 Medical Device Companies
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2019-2025)
8.6.2.3 Forecast Trend (2026-2035)
8.6.3 Academic Institutes
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2019-2025)
8.6.3.3 Forecast Trend (2026-2035)
8.6.4 Others
8.7 Latin America Contract Research Organisation (CRO) Services Market by Country
8.7.1 Market Share
8.7.1.1 Brazil
8.7.1.2 Argentina
8.7.1.3 Mexico
8.7.1.4 Others
9 Regional Analysis
9.1 Brazil
9.1.1 Historical Trend (2019-2025)
9.1.2 Forecast Trend (2026-2035)
9.2 Argentina
9.2.1 Historical Trend (2019-2025)
9.2.2 Forecast Trend (2026-2035)
9.3 Mexico
9.3.1 Historical Trend (2019-2025)
9.3.2 Forecast Trend (2026-2035)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Powers
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Key Company Profiles
12.2.1 Charles River Laboratories International, Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Clinipace
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Clintec International Ltd.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 IQVIA
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Parexel International Corporation
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
13 Industry Events and Developments